Professional Documents
Culture Documents
Update
Status Epilepticus in
Children
Adult
Pregnancy
Childbearing
1
Status Epilepticus (SE)
The term status epilepticus may be used to describe any
continuing type of seizure.
3
Causes of SE
Diagnosis Children (%) Adults (%)
Stroke 3 25
Drug change/noncompliance 20 20
Alcohol/other drugs 2 15
CNS infection 5 10
Hypoxia 5 10
Metabolic 10 10
Tumor <1 5
Trauma 3.5 5
Fever/infection 35 2
Congenital 10 <1
4
Causes of SE
5
SE Classification
6
Non Colvulsive
Status Epilepticus
NCSE refers to continuous seizure activity
without predominant motor activity.
7
Patomekanisme Status
Epilepticus
Proses dasar dari munculnya SE adalah
gagalnya mekanisme normal untuk mengakhiri
serangan.
Inhibisi yang menurun dan excitasi yang
persisten menimbulkan aktifitas serangan yang
berlangsung terus menerus.
Selama aktifitas serangan yang berkepanjangan,
terjadi perubahan dinamika pada fungsi reseptor
GABAA dan fungsi reseptor NMDA yang dikenal
dengan receptor traficking.
8
Patomekanisme Status
Epilepticus cont.
Aktifitas serangan yang berlangsung terus akan
mengurangi secara bertahap reseptor2 GABAA
pada synaptic membrane diikuti dengan
internalisasi reseptor ke dalam vesikel2
endositotik dan degradasi berikutnya.
Proses ini berakibat pada erosi endogen GABA
ergic inhibisi yang akan meningkatkann aktifitas
epileptic berkepanjangan.
9
Patomekanisme Status
Epilepticus cont.
Hilangnya reseptor GABAA post sinaptik
merupakan factor patofisiologik yg relevan
sehingga terjadi farmakoresisten terhadap obat2
seperti benzodiazepine, barbiturate dan propofol.
Sebaliknya, selama aktifitas epileptic berlangsung,
reseptor NMDA secara progresif berpindah ke
synaptic membrane, sehingga menambah
reseptor NMDA exitatorik presynaps. Proses ini
memudahkan exitabilitas neuron dan berikutnya
memperpanjang SE.
10
Patomekanisme Status
Epilepticus cont.
11
Seizures produce a number of
physiologic consequences.
12
Seizures produce a number of
physiologic consequences. Cont.
14
Differential Diagnosis
of Status Epilepticus
A number of conditions mimic seizures. These
include convulsive syncope (with or without cardiac
dysrhythmias), decerebrate posturing, psychogenic
events, dystonia, and migraine headaches.
Patients with strychnine poisoning may develop
seizure-like activity yet demonstrate normal mental
status.
15
Management of
Status Epilepticus
oPrehospital Concerns
oEmergency Departement
oICU
16
Prehospital Concerns
17
Prehospital Concerns cont..
In most cases, pre-hospital personnel will arrive at
least 5 minutes after the onset of seizure activity,
such that patients who are still seizing should be
managed as presumed status epilepticus.
18
Prehospital Concerns cont..
When IV access is not immediately available, rectal
diazepam is an option.
One prospective study reported that there were no
significant differences between rectal and
intravenous diazepam therapy with regard to SE
duration, intubation, or recurrent seizures in the
emergency department (ED).
These data suggest that prehospital administration
of diazepam may shorten the duration of SE in
children and simplify the subsequent management.
19
Prehospital Concerns cont..
In a retrospective study on prehospital seizure
management in children, rectal diazepam (5 mg/kg),
was compared to IM midazolam(15 mg /kg).
Over the 4 year study period,
2566 children presented with seizures and
107 children were eligible for entry into the study.
Of these 107 patients received diazepam
and 45 received midazolam.
20
Prehospital Concerns cont..
Both drugs were effective in stopping seizures within
5 minutes of drug administration; however, fewer
patients in the midazolam group suffered apnea.
21
Prehospital Concerns cont..
Vilke et al compared IM to IV midazolam and
reported that IV delivery was more effective:
47/49 in the IV group vs 20/25 with IM
administration (p less than 0.05).
Four patients (three treated IM and one IV) had
respiratory compromise necessitating field airway
management. In light of the Chamberlain and Vilke
studies, some experts recommend IV midazolam as
the agent of choice in the prehospital management
of seizures.
22
Diagnostic Testing
Laboratory
Tests include a determination of :
serum glucose
electrolytes
urea nitrogen, creatinine
magnesium, phosphate, calcium
complete blood count
pregnancy tests
anti-epileptic drug levels
liver function tests
drugs of abuse screening.
23
Status Epilepticus
Clinical manifestations
Convulsive SE
Related to acutely elevated serum
catecholamine levels
Respiratory interference
Cardiovascular system adversely affected
Acidosis and rhabdomyolysis
Hyperkalemia
Myoglobinuria
24
Status Epilepticus
Clinical manifestations
Nonconvulsive SE (10-15%)
Obtundation
underlying systemic or neurological disorder
sedating or paralyzing medication
Alterations in behavior
Slow mentation
Confusion
Stupor coma
Unexplained, prolonged coma
25
Subtle clinical and physiological
changes in Nonconvulsive Seizures
Clinical changes Physiological changes
Early Hyperglycemia
Tachycardia Acidosis respiratory and
Hypertension metabolic
Eye deviation Increased prolactin
Facial twitch
Rapid and deep
respiration
Salivation
Pupillary dilation
Desaturation EEG should be considered if any
Late of these symptoms detected in a
Hypotension patient with unexplained coma
Hypo- or hyperthermia
26
Protocol for Convulsive SE
Minutes 0-5
100% O2 by mask or canula
Head position for airway patency
Assist ventilation if necessary
Cardiac monitoring
Record vital signs: BP, temperature, etc.
Check glucose
Establish IV
Draw blood for glucose, chemistry, CBC, toxicology,
antiseizure medication level, etc.
27
Protocol for Convulsive SE
Minutes 5-15
Thiamine 100 mg IV and 50 ml D50W if indicated
Sedatives
Lorazepam (ativan) 0.1 mg/kg IV, 2 mg/min, OR
Diazepam (valium) 0.2 mg/kg IV, 5 mg/min, OR
Diazepam (valium) 0.5 mg/kg per rectum (if no IV)
Anticonvulsant
Fosphenytoin 15-20 mg/kg IV, 150 mg/min, OR
Phenytoin (dilantin) 15-20 mg/kg IV, 50 mg/min, OR
Valproic acid (depakin) 800 mg IV
Monitor BP and cardiac rhythm
Do not infuse phenytoin through a line containing
glucose
28
Protocol for Convulsive SE
Minutes 15-30
Repeat lorazepam or diazepam if seizure continues
Additional fosphenytoin or phenyoin in increments dose of
5 mg/kg to total 30 mg/kg
Minutes 30-60
Monitor respirations because patient may require assisted
ventilation (intubation). Monitor EEG.
If status persists, give phenobarbital 20 mg/kg, 100 mg/min
Midazolam (dormicum) IV infusion (0.2 mg/kg slow bolus;
0.1-2.0 mg/kg/hr)
Propofol 1-5 mg/kg bolus over 5 min, then 2-4 mg/kg/hr
Minutes 60 or more
If status remains refractory, consider pentobarbital 5 mg/kg
load, then 1-4 mg/kg/h infusion
29
Treatment of Nonconvulsive SE
Treatment
IV diazepam (5-10 mg), or
IV lorazepam (1-2 mg)
Disappearance of epileptiform EEG
abnormality and improvement of mental state
Long-term seizure control
IV phenytoin, phenobarbital, valproic acid
Oral gabapentin (Neurontin) or levetiracetam
(Keppra)
30
Seizures continuing stage of
Refractory Status Epilepticus
General anesthesia should be induced
Propofol : 2mg/kg IV bolus, Repeat if necessary, followed by
infusion (5mg/kg/hr)
Thiopental : 100-250mg IV bolus over 20 sec. with further
50mg bolus every 2-3 min.until seizure control followed by IV
infusion(3-5mg/kg/hr)
Midazolam : 0.1-0.3mg/kg IV bolus dose at the rate of 4mg/min
followed by infusion(0.05-0.4mg/kg/hr)
If seizures have been controlled for 12hrs., reduce the dose
over further 12hrs.
If seizure recurs again GA agent should be given
Lancet Neurol 2006; 5: 252
Differential Diagnosis Of Altered
Mental Status In The Patient
Who Has Seized
Post-ictal state
NCSE or subtle convulsive status
Hypoglycemia
CNS infection
CNS vascular event
Drug toxicity
Psychiatric disorder
33
Nonconvulsive
Status Epilepticus (NCSE)
NCSE, like convulsive status epilepticus, is a state of
continuous or intermittent seizure activity lasting more
than thirty minutes without a return to baseline function.
34
NCSE
Though the distinction is not clear in the
literature, NCSE in general should be
distinguished from subtle GCSE, which is the
end stage of GCSE, associated with anoxic
brain injury, and has a very poor prognosis.
35
Treatment of NCSE
36
Special Situations
Alcohol Withdrawal Seizures (AWS)
38
Eclampsia
Complications, such as respiratory depression
and pneumonia, were also less for magnesium
than for phenytoin.
Magnesium showed a trend towards increased
incidence of renal failure when compared to
phenytoin; however, this was not statistically
significant. Magnesium sulfate was also
associated with benefits for the baby, including
fewer admissions to the NICU.
39
Eclampsia
In the eclamptic patient, give 4 grams of
intravenous magnesium sulfate followed by a
2 gm/h drip (some centers use intramuscular
regimens).
Control the patients blood pressure if very high
(SBP greater than 160 and/or DBP greater than
110)
40
Febrile Seizures
41
Febrile Seizures
Ten to 50% of cases of status epilepticus in children
are associated with febrile seizures; status in this
group is a consistent predictor of increased risk for
subsequent seizures.
Simple febrile seizures are a benign process.
When they occur in children older than 18 months
who have not been on antibiotics, they do not
require any particular diagnostic work-up, even for a
first time event. Management focuses on a careful
history and physical, and on parental education.
42
Febrile Seizures
Two to four percent of all children will have a simple
febrile seizure. Children who have had a febrile seizure
have a 25 to 50% chance of having a second event,
usually within a year. Children at highest risk for
recurrence are those with a first degree relative who has
had a febrile seizure, complex first febrile seizure, or age
younger that one year when the first event occurred.
There is an increased incidence of developing epilepsy in
children who have had a simple febrile seizure (2.4%
versus a .4% incidence in the general population).
43
Febrile Seizures
Patients with simple febrile seizures require no special
workup or treatment. Reassuring the parents is often the
most Herculean task. Nearly half of parents think that
their child is dying during the seizure. Such concerns
need to be addressed; simply suggesting the child be
discharged on acetaminophen is not appropriate.
44
Non-Febrile Seizures
The evaluation of non-febrile seizures, complex seizures, and
febrile seizure outside of the usual age group, in essence, parallels
the discussion presented on adults in the preceding sections. If the
seizure was exertional, consider the possibility of convulsive
syncope secondary to a cardiac arrhythmia. In children, this could
be due to a prolonged QT syndrome or hypertrophic
cardiomyopathy. During the evaluation, be attentive to the
stigmata of the phakomatoses (hereditary disease characterized by
tumors in multiple tissues) such caf au lait spots (tuberous
sclerosis) or fleshy bumps (neurofibromatosis). Both of these may
result in seizures secondary to CNS tumors.
45
Status Epilepticus
In Children
The treatment of status seizures in children is similar to
that of adults. Interosseous access is an alternative when
intravenous access is not secured. While rectal diazepam
has long been used as an alternative to parenteral
administration in children, buccal midazolam may be
equally effective (and more palatable).
Intranasal midazolam (0.2 mg/kg) has been reported to
have equal efficacy with IV diazepam (0.3 mg/kg) for
prolonged febrile seizures.
.
46
Status Epilepticus
in Children
Both phenytoin and phenobarbital are often effective in
pediatric status if a bolus administration of a benzodiazepine
fails. However, as in adults, continuous infusion of
benzodiazepines have been reported as successful. Infection
has been reported as a more common cause of status in
children than in adults. Therefore, many physicians will
empirically cover such children with broad-spectrum
antibiotics, usually ceftriaxone (or the combination of
ceftriaxone and amoxicillin in neonates). The routine use of
empiric acyclovir to treat presumed herpes encephalitis in the
neonate remains unstudied.
47
Status Epilepticus
in Children
Status epilepticus (SE) presents in a
multitude of forms, dependent on
etiology and patient age (myoclonic,
tonic, subtle, tonic-clonic, absence,
complex partial etc.)
Generalized, tonic-clonic SE is the most
common form of SE
48
Causes
Fever 36%
Medication change. 20%
Unknown.. 9%
Metabolic. 8%
Congenital 7%
5%
Anoxic...
Other (trauma, vascular, infection,
tumor, drugs)... 15%
49
Drugs which can cause seizures
Antibiotics Psychopharmaceuticals
Penicillins Antihistamines
Isoniazid Antidepressants
Metronidazole Antipsychotics
Anesthetics, narcotics Phencyclidine
Halothane, enflurane Tricyclic antidepressants
Cocaine, fentanyl
Ketamine
50
Mortality
Adults 15 to 22%
Children 3 to 15%
51
Prolonged seizures
Duration of seizure
52
Respiratory
Hypoxia and hypercarbia
53
Hypoxia
Hypoxia/anoxia markedly increase the risk
of mortality in SE
Seizures (without hypoxia) are much less
dangerous than seizures and hypoxia
54
Neurogenic pulmonary edema
Rare complication
Likely occurs as
consequence of marked
increase of pulmonary
vascular pressure
Respiratory
Lactic
Impaired tissue oxygenation
Increased energy expenditure
56
Hemodynamics
Sympathetic overdrive
Massive catecholamine /
autonomic discharge
Hypertension
Tachycardia
High CVP Exhaustion
Hypotension
hypoperfusion
0 min 60 min
57
Cerebral blood flow
Cerebral O2 requirement
Hyperdynamic phase
CBF meets CMRO2
O2 requirement Exhaustion phase
CBF drops as
Hypotension sets in
Autoregulation
exhausted
Blood flow
Neuronal demage
ensue
Blood pressure
Seizure duration
58
Glucose Glucose
SE
30 min
SE + hypoxia
Seizure duration
59
Hyperpyrexia
60
Other alterations
Blood leukocytosis (50% of children)
Spinal fluid leukocytosis (15% of children)
K+
Creatine kinase
Myoglobinuria
61
Oxygen, oral airway. Avoid
A hypoxia!
62
Treatment
Arterial blood gas?
All children in SE have acidosis. It often resolves
rapidly with termination of SE
Intubate?
It may be difficult to intubate the actively seizing
child
Stop or slow seizures first, give O2, consider BVM
ventilation
If using paralytic agent to intubate, assume that SE
continues
63
Initial investigations
Labs
Na, Ca, Mg, PO4 , glucose
CBC
Liver function tests, ammonia
Anticonvulsant level
Toxicology
64
Initial investigations
Lumbar puncture
Always defer LP in unstable patient, but never
delay antibiotic/antiviral rx if indicated
CT scan
Indicated for focal seizures or deficit, history of
trauma or bleeding d/o
65
Treatment
give Glucose (2-4 ml/kg D25%, infants 5 ml/kg D10%),
unless normo- or hyperglycemic
66
Treatment
Hyponatremia:
Give 5 cc/kg of 3% (hypertonic saline)
Hypocalcemia:
Give 20-25 mg/kg of Calcium Chloride
67
Treatment
68
Anticonvulsants
Rapid acting
plus
Long acting
69
Anticonvulsants - Rapid acting
Benzodiazepines
Lorazepam 0.1 mg/kg i.v. over 1-2 minutes
Diazepam 0.2 mg/kg i.v. over 1-2 minutes
70
Benzodiazepines
Lorazepam Diazepam
Low lipid solubility High lipid solubility
Action delayed 2 minutes Thus very rapid onset
Anticonvulsant effect 6-12 hrs Redistributes rapidly
Less respiratory depression than
diazepam
Thus rapid loss of
anticonvulsant effect
Adverse effects are
persistent:
Midazolam Hypotension
May be given i.m. Respir depression
71
Anticonvulsants - Long acting
Phenytoin Fosphenytoin
20 mg/kg i.v. over 20 min 20 mg PE/kg i.v. over 5-7
min PE = phenytoin equivalent
pH 12 pH 8.6
Extravasation causes Extravasation well
severe tissue injury tolerated
Onset 10-30 min Onset 5-10 min
May cause hypotension, May cause hypotension
dysrhythmia
Cheap Expensive
72
Anticonvulsants - Long acting
Phenobarbital
20 mg/k g i.v. over 10 - 15 min
Onset 15-30 min
May cause hypotension, respiratory depression
73
Initial choice of long acting
anticonvulsants in SE
Is patient an infant?
Is patient already receiving phenytoin?
No Yes
No Yes
Phenytoin Fosphenytoin
74
If SE persists
75
NCSE?
Neurologic signs after termination
of SE are common:
Pupillary changes
Abnormal tone
Babinski
Posturing
Clonus
May be asymmetrical
76
NCSE?
77
NCSE?
78
Management of a pregnant
patient in status epilepticus
Establish the ABCs, and check vital signs, including
oxygenation.
Assess the fetal heart rate or fetal status.
Rule out eclampsia.
Administer a bolus of lorazepam (0.1 mg/kg, ie, 5-10 mg) at
no faster than 2 mg/min.
Load phenytoin (20 mg/kg, ie, 1-2 g) at no faster than 50
mg/min, with cardiac monitoring.
If this is not successful, load phenobarbital
(20 mg/kg, ie, 1-2 g) at no faster than 100 mg/min.
Check laboratory findings, including electrolytes, AED levels,
glucose, and toxicology screen.
If fetal testing results are nonreassuring, move to emergent
delivery.
79
80
Management of WWE
upon labor and delivery
Check levels of antiepileptic drugs (AEDs).
Inform all care providers, including nurses,
anesthesiologists, and pediatricians, that the patient has
epilepsy.
Consider seizure prophylaxis with intravenous
benzodiazepines or phenytoin.
Manage seizures acutely with intravenous benzodiazepines
(1-2 mg of diazepam), then load phenytoin (1 g loaded over
1 h).
Labor management should be based on routine standards
of care.
Start administration of vitamin K for the infant, and send
the cord blood for clotting studies.
81
Alhamdulillahirobbil alamin
Semoga bermanfaat
82